Prognostic significance of albumin to alkaline phosphatase ratio in critically ill patients with acute kidney injury

• Published in: Clinical and experimental nephrology Vol. 26; no. 9; pp. 917 - 924
• Main Authors: Xia, Wenkai, Zhao, Danyang, Li, Chenyu, Xu, Lingyu, Yao, Xiajuan, Hu, Hong
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 01.09.2022; Springer Nature B.V
• Subjects: Albumin; Alkaline phosphatase; Epidemiology; Kidneys; Medicine; Medicine & Public Health; Mortality; Multivariate analysis; Nephrology; Original Article; Patients; Phosphatase; Urology; Albumin; Alkaline phosphatase; Prognosis; Acute kidney injury
• ISSN: 1342-1751; 1437-7799; 1437-7799
• DOI: 10.1007/s10157-022-02234-9

Objective No epidemiological evidence has investigated the effect of albumin to alkaline phosphatase ratio (AAPR) on the prognosis among critically ill patients with acute kidney injury (AKI). We aimed to explore the prognostic value of AAPR in these patients. Methods We extracted all clinical data from MIMIC III. ROC curve analysis was used to evaluate the discrimination of AAPR for predicting in-hospital mortality. A generalized additive model was applied to identify a nonlinear association between AAPR and in-hospital mortality. The Cox proportional hazards models were used to determine the association between AAPR and in-hospital and 30-day mortality. Results A total of 6894 eligible subjects were enrolled in this study. The relationship between AAPR and in-hospital mortality was nonlinear. Multivariate analysis demonstrated that lower AAPR (AAPR < 0.35) was an independent predictor of in-hospital and 30-day mortality after adjusting for potential confounders (HR 1.74, 95% CI 1.72–2.20, P  < 0.001; HR 1.89, 95% CI 1.66–2.14, P  < 0.001, respectively). Conclusions AAPR may serve as a potential prognostic biomarker in critically ill patients with AKI and lower AAPR was associated with increased risk of in-hospital and 30-day mortality among these patients.